The AASM urges physician members to participate in a national study being conducted by the American Medical Association (AMA), and supported by 173 health care organizations including the AASM, to collect representative data on physician practice expenses. The aim of the Physician Practice Information [...]
The AASM joins the American Medical Association (AMA) in strongly supporting the Strengthening Medicare for Patients and Providers Act (H.R. 2474), a bipartisan measure now pending in the 118th Congress, which would provide the crucial link between the Medicare physician payment schedule and the [...]
The AASM has been reaching out to Blue Shield of California leadership over the past two months regarding the payer’s denial of reimbursement for positive airway pressure (PAP) therapy when a device with only one respiratory monitoring belt is used in performing the patient’s [...]
After receiving a letter submitted by the American Medical Association (AMA) and more than 100 medical societies, including the American Academy of Sleep Medicine (AASM), Cigna has announced a delay in implementation of its recently revised modifier 25 policy. Modifier 25 enables reporting of [...]
On May 3, the Drug Enforcement Administration (DEA) published a temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications for six months, from May 12, 2023, through Nov. 11, 2023, provided all appropriate conditions are met. The rule also provides for a [...]
On April 5, 2023, the Centers for Medicare & Medicaid Services (CMS) published the Medicare Advantage and Part D final rule. This rule summarizes finalized changes to the Medicare Advantage (Medicare Part C), prescription benefit coverage (Medicare Part D), Medicare Cost Plan, and Programs [...]
Palmetto GBA, a Medicare administrative contractor (MAC) for Medicare jurisdictions J and M, revised the polysomnography Local Coverage Determination (LCD) L36593 and its accompanying Local Coverage Article A56995 effective March 16, 2023, to update documentation and billing requirements. These jurisdictions include Alabama, Georgia, Tennessee, [...]
After receiving several inquiries from AASM members expressing concern that Blue Shield of California is denying reimbursement for positive airway pressure (PAP) therapy when a device with only one respiratory monitoring belt is used in performing the patient’s diagnostic sleep study, the AASM sent [...]
The AASM continues to advocate for prior authorization reform to allow clinicians to provide medically necessary care in a timely manner for patients with sleep disorders. Medicare Advantage organizations are currently at the forefront of national reform efforts, given recent studies and initiatives, by [...]
The AASM worked with the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS) to convert 12 phrenic nerve stimulation (PNS) Category III codes to Category I codes. The AMA Current Procedural Terminology (CPT) Editorial Panel accepted the addition of codes 3X008-3X015 [...]
